Vesper Bio
Ditte Nedergaard Mikkelsen is a Clinical Trial Associate currently working at Genmab since February 2023, with extensive experience in clinical trials and project management. This professional's background includes roles at TFS HealthScience and AstraZeneca, where oversight of CRO document collection and site visits were key responsibilities. Previous positions also include administrative support at SMM Nordic, event coordination at Kvindemuseet i Danmark, and various roles in museum settings, enhancing skills in project planning, logistics, and stakeholder collaboration. Ditte holds a Master's degree in Museology from Lund University and a Bachelor's degree in Near Eastern Archaeology from the University of Copenhagen.
This person is not in any teams
Vesper Bio
Vesper Biotechnology is a clinical stage biotech company and world leader in sortilin biology. Vesper's VES001 is being developed for FTD(GRN) and is in phase I.